Michael Pappas, MD
Orthopaedic Surgery · Mount Pleasant, TXNPI 1265432355
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 42.8% of the total. Reporting peaked in 2019 at $2,748 and has fallen 79.9% since, to $553 in 2025.
Across 118 payments — averaging $50.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$2K
- Bioventus LLC$176
- Gemini Mountain Medical, LLC$131
- Gemini Medical LLC$100
- Johnson & Johnson$90
- plus $484 from 13 others
What the payments were for
- Travel & lodging$1,56026%
- Food & beverage$2,61944%
- Education$1,74729%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 66 | $2,538 |
| Arthrex | 13 | $2,407 |
| Bioventus LLC | 8 | $176 |
| Gemini Mountain Medical, LLC | 3 | $131 |
| Gemini Medical LLC | 1 | $100 |
| Johnson & Johnson | 4 | $90 |
| Innovation Technologies Inc | 3 | $86 |
| Pacira Therapeutics, Inc. | 3 | $70 |
| Vertex | 3 | $55 |
| Zimmer Biomet | 1 | $46 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Pylant Medical | 2 | $35 |
| Treace Medical Concepts, Inc. | 1 | $28 |
| Medtronic | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Amgen | 1 | $24 |
| Vericel Corporation | 1 | $23 |
| Orthofix Medical, Inc. | 3 | $21 |
| Orthogenrx Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$904
- AEQUALIS ASCEND FLEX$229
How this compares
$5,926 in reported general payments places this provider in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 112 | $961 |
| Cephalexin | 68 | $153 |
| Doxycycline Hyclate | 11 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $124 |
| Methylprednisolone | 17 | $118 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $93 |
| Tramadol Hcl | 20 | $76 |
| Amoxicillin | 16 | $10 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mount Pleasant
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.